Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review

Babasola O Okusanya, Ibitola O Asaolu, John E Ehiri, Linda Jepkoech Kimaru, Abidemi Okechukwu, Cecilia Rosales, Babasola O Okusanya, Ibitola O Asaolu, John E Ehiri, Linda Jepkoech Kimaru, Abidemi Okechukwu, Cecilia Rosales

Abstract

Background: Medical cannabis (MC) is currently being used as an adjunct to opiates given its analgesic effects and potential to reduce opiate addiction. This review assessed if MC used in combination with opioids to treat non-cancer chronic pain would reduce opioid dosage.

Methods: Four databases-Ovid (Medline), Psyc-INFO, PubMed, Web of Science, and grey literature-were searched to identify original research that assessed the effects of MC on non-cancer chronic pain in humans. Study eligibility included randomized controlled trials, controlled before-and-after studies, cohort studies, cross-sectional studies, and case reports. All databases were searched for articles published from inception to October 31, 2019. Cochrane's ROBINS-I tool and the AXIS tool were used for risk of bias assessment. PRISMA guidelines were followed in reporting the systematic review.

Results: Nine studies involving 7222 participants were included. There was a 64-75% reduction in opioid dosage when used in combination with MC. Use of MC for opioid substitution was reported by 32-59.3% of patients with non-cancer chronic pain. One study reported a slight decrease in mean hospital admissions in the past calendar year (P = .53) and decreased mean emergency department visits in the past calendar year (P = .39) for patients who received MC as an adjunct to opioids in the treatment of non-cancer chronic pain compared to those who did not receive MC. All included studies had high risk of bias, which was mainly due to their methods.

Conclusions: While this review indicated the likelihood of reducing opioid dosage when used in combination with MC, we cannot make a causal inference. Although medical cannabis' recognized analgesic properties make it a viable option to achieve opioid dosage reduction, the evidence from this review cannot be relied upon to promote MC as an adjunct to opioids in treating non-cancer chronic pain. More so, the optimal MC dosage to achieve opioid dosage reduction remains unknown. Therefore, more research is needed to elucidate whether MC used in combination with opioids in the treatment of non-cancer chronic pain is associated with health consequences that are yet unknown.

Systematic review registration: This systematic review was not registered.

Keywords: Medical cannabis; Opioid crisis; Opioid epidemic; Opioid substitution.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Detailed study selection process

References

    1. Solving Medical Mysteries | Blood Clots That Kill | Coping with Food Allergies. . Accessed 23 July 2020.
    1. Dahlhamer J, Lucas J, Zelaya C, et al. Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016. MMWR Morbidity and mortality weekly report. 2018;67(36):1001–1006. doi: 10.15585/mmwr.mm6736a2.
    1. Drug Overdose Deaths | Drug Overdose | CDC Injury Center. . Accessed 23 July 2020.
    1. Rosenblum A, Marsch LA, Joseph H, Portenoy RK. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol. 2008;16(5):405–416. doi: 10.1037/a0013628.
    1. Busse JW, Wang L, Kamaleldin M, et al. Opioids for chronic noncancer pain: a systematic review and meta-analysis. Jama. 2018;320(23):2448–2460. doi: 10.1001/jama.2018.18472.
    1. Kosten TR, George TP. The neurobiology of opioid dependence: implications for treatment. Sci Pract Perspect. 2002;1(1):13–20. doi: 10.1151/spp021113.
    1. Desai UPP. Medical marijuana: a public health perspective. Int J Basic Clin Pharmacol. 2017;2(2):136–143. doi: 10.5455/2319-2003.ijbcp20130305.
    1. Hill MV, McMahon ML, Stucke RS, Barth RJ., Jr Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg. 2017;265(4):709–714. doi: 10.1097/SLA.0000000000001993.
    1. Governing . State Marijuana Laws in 2019 Map. 2019.
    1. Stockings E, Campbell G, Hall WD, et al. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies. Pain. 2018;159(10):1932–1954. doi: 10.1097/j.pain.0000000000001293.
    1. Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2018;3(3):Cd012182.
    1. Abrams DI, Couey P, Shade SB, Kelly ME, Benowitz NL. Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther. 2011;90(6):844–851. doi: 10.1038/clpt.2011.188.
    1. Corroon JM, Jr, Mischley LK, Sexton M. Cannabis as a substitute for prescription drugs - a cross-sectional study. J Pain Res. 2017;10:989–998. doi: 10.2147/JPR.S134330.
    1. Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: a systematic review and meta-analysis. Jama. 2015;313(24):2456–2473. doi: 10.1001/jama.2015.6358.
    1. Hill KP. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review. Jama. 2015;313(24):2474–2483. doi: 10.1001/jama.2015.6199.
    1. Campbell G, Stockings E, Nielsen S. Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain. Eur Arch Psychiatry Clin Neurosci. 2019;269(1):135–144. doi: 10.1007/s00406-018-0960-9.
    1. Downes MJ, Brennan ML, Williams HC, Dean RS. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS) BMJ Open. 2016;6(12):e011458. doi: 10.1136/bmjopen-2016-011458.
    1. Barlowe TS, Koliani-Pace JL, Smith KD, Gordon SR, Gardner TB. Effects of medical cannabis on use of opioids and hospital visits by patients with painful chronic pancreatitis. Clin Gastroenterol Hepatol. 2019;17(12):2608–2609. doi: 10.1016/j.cgh.2019.01.018.
    1. Vigil JM, Stith SS, Adams IM, Reeve AP. Associations between medical cannabis and prescription opioid use in chronic pain patients: a preliminary cohort study. PLoS One. 2017;12(11):e0187795. doi: 10.1371/journal.pone.0187795.
    1. Campbell G, Hall WD, Peacock A, et al. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. Lancet Public Health. 2018;3(7):e341–e350. doi: 10.1016/S2468-2667(18)30110-5.
    1. Boehnke KF, Litinas E, Clauw DJ. Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. J Pain. 2016;17(6):739–744. doi: 10.1016/j.jpain.2016.03.002.
    1. Degenhardt L, Lintzeris N, Campbell G, et al. Experience of adjunctive cannabis use for chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) study. Drug Alcohol Dependence. 2015;147:144–150. doi: 10.1016/j.drugalcdep.2014.11.031.
    1. Lucas P, Baron EP, Jikomes N. Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients. Harm Reduction J. 2019;16(1):9. doi: 10.1186/s12954-019-0278-6.
    1. Lucas P, Walsh Z. Medical cannabis access, use, and substitution for prescription opioids and other substances: a survey of authorized medical cannabis patients. Int J Drug Policy. 2017;42:30–35. doi: 10.1016/j.drugpo.2017.01.011.
    1. Piper BJ, DeKeuster RM, Beals ML, et al. Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep. J Psychopharmacol (Oxford, England) 2017;31(5):569–575. doi: 10.1177/0269881117699616.
    1. Lynch ME, Clark AJ. Cannabis reduces opioid dose in the treatment of chronic non-cancer pain. J Pain Symptom Manage. 2003;25(6):496–498. doi: 10.1016/S0885-3924(03)00142-8.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren